HealthCor Management »

Blueprint Medicines shares owned by HealthCor Management

Quarter-by-quarter ownership of Blueprint Medicines (BPMC) shares owned by HealthCor Management from 13F filings

Historical chart of HealthCor Management investment in Blueprint Medicines

Tip: Access up to 7 years of quarterly data

All positions including Blueprint Medicines held by HealthCor Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Blueprint Medicines by HealthCor Management

Quarter filed Position value Share count Share price at filing
2022-12-31 $1.3M 30k 43.81
2022-09-30 $6.9M 105k 65.89
2020-06-30 $58M 743k 78.00
2020-03-31 $75M 1.3M 58.48
2019-12-31 $25M 309k 80.11
2019-09-30 $45M 609k 73.47
2019-06-30 $36M 383k 94.33

More positions owned by HealthCor Management

BioMarin Pharmaceutical (BMRN)
Dex (DXCM)
Cytokinetics Com New (CYTK)
Acrivon Therapeutics Common Stock (ACRV)
Hyperfine Com Cl A (HYPR)
Alkermes SHS (ALKS)
CONMED Corporation (CNMD)
Neurocrine Biosciences (NBIX)
Syndax Pharmaceuticals (SNDX)
Chinook Therapeutics
Intuitive Surgical Com New (ISRG)
Blueprint Medicines (BPMC)
Geron Corporation (GERN)
Penumbra (PEN)
Rocket Pharmaceuticals (RCKT)

View all positions for HealthCor Management

Top funds holding Blueprint Medicines

DekaBank Deutsche Girozentrale
Huntington National Bank

View all funds holding Blueprint Medicines